2021 annual financial data
Regeneron Pharmaceuticals 2021 Operating cash flow margin
Regeneron Pharmaceuticals 2021 operating cash flow margin with verified reporte…
Direct answer
Operating cash flow margin was 44.06%.
Operating income was 8,946,800,000 USD and net income was 8,075,300,000 USD.
Operating cash flow was 7,081,300,000 USD.
Get free Regeneron Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 16,071,700,000 USD
- Operating income
- 8,946,800,000 USD
- Net income
- 8,075,300,000 USD
- Operating cash flow
- 7,081,300,000 USD